Hemagglutination inhibition antibody titers
9 papers study it2 more mention it9 findings
- Human trial3
- Humans6
Upstream
1ILT2+ CD57+ CD56dim NK cell frequency
mediatesin humans1
1 study
ILT2+ CD57+ CD56dim NK cell frequency
mediatesin humans1
ILT2+ CD57+ CD56dim NK cell frequency mediates hemagglutination inhibition antibody titers in humans (40%).
“ILT2(+)CD57(+) Dim NK-cells mediated 40% of the association between IL-6 and A/H3N2 titres”
Human trialassociation between IL-6 and A/H3N2 titres
Immunity & ageing : I & A
Associations
8Antigen-specific CD4+ T cell frequency
upin humans1
1 study
Antigen-specific CD4+ T cell frequency
upin humans1
Antigen-specific CD4+ T cell frequency is associated with hemagglutination inhibition antibody titers in humans (r = 0.42).
“correlated with lower H3N2 hemagglutination inhibition antibody titers (r = 0.42, P = 0.008)”
Humansin responders following vaccinationn = 34
Influenza vaccine-specific CD4⁺ T cell responses are impaired in older adults
NPJ vaccines
TNFSF10+ LGALS9+ NK cells
upin humans1
1 study
TNFSF10+ LGALS9+ NK cells
upin humans1
TNFSF10+ LGALS9+ NK cells are associated with hemagglutination inhibition antibody titers in humans.
“their increased frequency correlates with high pre-existing HAI titers, suggesting a link between adaptive-like NK responses and humoral immunity.”
Humans
bioRxiv : the preprint server for biologyPreprint
Immunotypes
mixedin humans1
1 study
Immunotypes
mixedin humans1
Immunotypes are associated with hemagglutination inhibition antibody titers in humans.
“we identified two pre-vaccination immunotypes associated with weak and one showing robust day 28 antibody response.”
Humanspre-vaccination immunotypeswhole blood28 daysn = 307
Pre-vaccination immunotypes reveal weak and robust antibody responders to influenza vaccination
Aging cell
Chronological age
downin humans1
1 study
Chronological age
downin humans1
Chronological age is associated with hemagglutination inhibition antibody titers in humans (rho = -0.3689, P < 0.0001).
“there was a significant negative correlation between chronological age (years) and post-vaccination HAI titers against H1N1 (rho = -0.2298, P < 0.0001), B/Victoria (rho = -0.2235, P = 0.0037), and B/Yamagata (rho = -0.3689, P < 0.0001).”
Human trialpost-vaccinationbloodn = 167
Immunity & ageing : I & A
Biological age
upin humans1
1 study
Biological age
upin humans1
Biological age is associated with hemagglutination inhibition antibody titers in humans (d = 0.16-0.26).
“advanced BA was associated with improved post-vaccination antibody titres against the different viral types and subtypes. However, this was dependent on both vaccine dose and CMV serostatus”
Human trialin high-dose vaccine recipientsfour consecutive seasonsn = 292
Immunity & ageing : I & A
ILT2+ CD57+ CD56dim NK cell frequency
upin humans1
1 study
ILT2+ CD57+ CD56dim NK cell frequency
upin humans1
ILT2+ CD57+ CD56dim NK cell frequency is associated with hemagglutination inhibition antibody titers in humans.
“frequency of ILT2(+)CD57(+) CD56-Dim natural killer (NK)-cells was positively associated with both plasma IL-6 and post-vaccination A/H3N2 titres”
Human trialfollow-up cohort of older high-dose recipientsn = 63
Immunity & ageing : I & A
Inflammation
upin humans1
1 study
Inflammation
upin humans1
Inflammation is associated with hemagglutination inhibition antibody titers in humans (d = 0.10-0.45).
“in older high-dose, but not standard-dose recipients, all systemic inflammatory mediators were positively associated with A/H1N1, A/H3N2 and B titres (d = 0.10-0.45)”
Human trialhigh-dose inactivated vaccine recipients
Immunity & ageing : I & A
IL-6
upin humans1
1 study
IL-6
upin humans1
IL-6 is associated with hemagglutination inhibition antibody titers in humans (Cohen's d = 0.36).
“IL-6 was positively associated with A/H3N2 titres in young adults (Cohen's d = 0.36)”
Human trialn = 79
Immunity & ageing : I & A